83 related articles for article (PubMed ID: 8542221)
21. Comparison of a subjective and a quantitative assessment of the neonatal chest radiograph.
Yuksel B; Greenough A; Karani J
Br J Radiol; 1992 Dec; 65(780):1083-5. PubMed ID: 1286414
[TBL] [Abstract][Full Text] [Related]
22. Natural surfactant instilled in premature lambs increases lung volume and improves ventilation homogeneity within five minutes.
Vilstrup C; Gommers D; Bos JA; Lachmann B; Werner O; Larsson A
Pediatr Res; 1992 Nov; 32(5):595-9. PubMed ID: 1480463
[TBL] [Abstract][Full Text] [Related]
23. The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease.
Cotton RB; Olsson T; Law AB; Parker RA; Lindstrom DP; Silberberg AR; Sundell HW; Sandberg K
Pediatr Res; 1993 Oct; 34(4):495-501. PubMed ID: 8255684
[TBL] [Abstract][Full Text] [Related]
24. Closure of the ductus arteriosus and mechanics of breathing in preterm infants after surfactant replacement therapy.
Heldt GP; Pesonen E; Merritt TA; Elias W; Sahn DJ
Pediatr Res; 1989 Mar; 25(3):305-10. PubMed ID: 2649864
[TBL] [Abstract][Full Text] [Related]
25. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment.
Dunn MS; Shennan AT; Zayack D; Possmayer F
Pediatrics; 1991 Mar; 87(3):377-86. PubMed ID: 2000278
[TBL] [Abstract][Full Text] [Related]
26. Surfactant replacement therapy in developing countries.
Vidyasagar D; Velaphi S; Bhat VB
Neonatology; 2011; 99(4):355-66. PubMed ID: 21701209
[TBL] [Abstract][Full Text] [Related]
27. Lung mechanics (FRC and static pressure-volume diagram) after endotracheal surfactant instillation: preliminary observations.
Svenningsen NW; Björklund L; Vilstrup C; Werner O
Biol Neonate; 1992; 61 Suppl 1():44-7. PubMed ID: 1391265
[TBL] [Abstract][Full Text] [Related]
28. Changes in dead space/tidal volume ratio and pulmonary mechanics after surfactant replacement therapy in respiratory distress syndrome of the newborn infants.
Chung EH; Ko SY; Kim IY; Chang YS; Park WS
J Korean Med Sci; 2001 Feb; 16(1):51-6. PubMed ID: 11289401
[TBL] [Abstract][Full Text] [Related]
29. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
[TBL] [Abstract][Full Text] [Related]
30. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group.
Online J Curr Clin Trials; 1992 Nov; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614
[TBL] [Abstract][Full Text] [Related]
31. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study].
Shinwell ES; Zmora E; Leven D; Berger I; Karplus M
Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835
[TBL] [Abstract][Full Text] [Related]
32. Respiratory distress syndrome treated with human surfactant: radiographic findings.
Edwards DK; Hilton SV; Merritt TA; Hallman M; Mannino F; Boynton BR
Radiology; 1985 Nov; 157(2):329-34. PubMed ID: 3840268
[TBL] [Abstract][Full Text] [Related]
33. [Use and efficacy of treatment with porcine surfactant in newborns with birth weight < or = 1000 g: experience in 3 years].
Brusamento S; Buffo M; Carnielli VP
Pediatr Med Chir; 1999; 21(6):261-5. PubMed ID: 11293146
[TBL] [Abstract][Full Text] [Related]
34. Lung surfactants for replacement therapy: biochemical, biophysical, and clinical aspects.
Notter RH; Shapiro DL
Clin Perinatol; 1987 Sep; 14(3):433-79. PubMed ID: 3311535
[TBL] [Abstract][Full Text] [Related]
35. Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants?
Tsakalidis C; Giougki E; Karagianni P; Dokos C; Rallis D; Nikolaidis N
Turk J Pediatr; 2012; 54(4):368-75. PubMed ID: 23692717
[TBL] [Abstract][Full Text] [Related]
36. Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery.
Cai J; Su Z; Zhou Y; Shi Z; Xu Z; Liu J; Xu Z; Yang Y
Eur J Cardiothorac Surg; 2011 Sep; 40(3):557-62. PubMed ID: 21371901
[TBL] [Abstract][Full Text] [Related]
37. Clinical use of single-dose surfactant TA therapy for premature infants with severe respiratory distress syndrome.
Deng HH; Kuo MC; Chung KH; Hsu HH; Lin ST
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1992; 33(6):408-16. PubMed ID: 1306925
[TBL] [Abstract][Full Text] [Related]
38. Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.
Levine D; Edwards DK; Merritt TA
AJR Am J Roentgenol; 1991 Aug; 157(2):371-4. PubMed ID: 1853824
[TBL] [Abstract][Full Text] [Related]
39. Factors affecting responses of infants with respiratory distress syndrome to exogenous surfactant therapy.
Ho NK
Singapore Med J; 1993 Feb; 34(1):74-7. PubMed ID: 8266136
[TBL] [Abstract][Full Text] [Related]
40. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
